Skip to main content
Log in

CAP significant public health burden in the US

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Yu H, et al. Clinical and Economic Burden of Community-Acquired Pneumonia in the Medicare Fee-for-Service Population. Journal of the American Geriatrics Society 60: 2137-2143, No. 11, 30 Oct 2012. Available from: URL: http://dx.doi.org/10.1111/j.1532-5415.2012.04208.x

Download references

Additional information

* Sponsored by Pfizer, Inc.

Rights and permissions

Reprints and permissions

About this article

Cite this article

CAP significant public health burden in the US. PharmacoEconomics & Outcomes News 668, 5 (2012). https://doi.org/10.1007/s40274-012-0014-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-012-0014-x

Navigation